Non–Small Cell Lung Cancer Symptom Assessment Questionnaire: Psychometric Performance and Regulatory Qualification of a Novel Patient-Reported Symptom Measure-Reference-Cited by-同舟云学术

Non–Small Cell Lung Cancer Symptom Assessment Questionnaire: Psychometric Performance and Regulatory Qualification of a Novel Patient-Reported Symptom Measure

Published:2021 Issue: Volume:95 Page:100642
ISSN:0011-393X
Container-title:Current Therapeutic Research
language:en
Short-container-title:Current Therapeutic Research

Author:

Bushnell Donald M.^ORCID,Atkinson Thomas M.^ORCID,McCarrier Kelly P.^ORCID,Liepa Astra M.,DeBusk Kendra P.,Coons Stephen Joel^ORCID

Funder

AbbVie

Novartis Pharmaceuticals Corporation

Publisher

Elsevier BV

Subject

Pharmacology (medical),Pharmacology

Reference35 articles.

1. Cancer statistics, 2018;Siegel;CA: A Cancer Journal for Clinicians,2018

2. Establishing the diagnosis of lung cancer: Diagnosis and management of lung cancer, 3rd ed: American College of Chest Physicians evidence-based clinical practice guidelines;Rivera;Chest,2013

3. Focusing on core patient-reported outcomes in cancer clinical trials: symptomatic adverse events, physical function, and disease-related symptoms;Kluetz;Clinical Cancer Research (Clin Cancer Res),2016

4. Reliability and validity of the Functional Assessment of Cancer Therapy-Lung (FACT-L) quality of life instrument;Cella;Lung Cancer,1995

5. The EORTC QLQ-LC13: a modular supplement to the EORTC core quality of life questionnaire (QLQ-C30) for use in lung cancer clinical trials;Bergman;European Journal of Cancer,1994

Cited by 5 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Developing a fit-for-purpose composite symptom score as a symptom burden endpoint for clinical trials in patients with malignant pleural mesothelioma;Scientific Reports;2024-06-27

2. International Society for Quality of Life Research commentary on the US Food and Drug Administration draft guidance for industry on core patient-reported outcomes in cancer clinical trials;Quality of Life Research;2023-05-23

3. Clinical perspectives on serum tumor marker use in predicting prognosis and treatment response in advanced non-small cell lung cancer;Tumor Biology;2023-05-23

4. Comparing patient global impression of severity and patient global impression of change to evaluate test–retest reliability of depression, non-small cell lung cancer, and asthma measures;Quality of Life Research;2022-07-19

5. Non-Small Cell Lung Cancer Symptom Assessment Questionnaire (NSCLC-SAQ): Measurement Properties and Estimated Clinically Meaningful Thresholds From a Phase 3 Study;JTO Clinical and Research Reports;2022-04